Dr. Sharmeen Samuel-Babcock is a specialty care physician board certified in general pediatrics and pediatric cardiology. She joined Inova in 2026 and has been practicing since 2019.
Prior to joining Inova, Dr. Samuel-Babcock was a general pediatric and fetal cardiologist at Johns Hopkins Regional Physicians.
Dr. Samuel-Babcock’s clinical areas of interest include the management of congenital heart disease and noninvasive cardiac imaging, including fetal echocardiography. She enjoys caring for pediatric patients of all ages with congenital heart disease. She is dedicated to putting patients first and providing excellent care to help achieve the best possible outcomes.
In her free time, Dr. Samuel-Babcock enjoys spending time outdoors, hiking, traveling, cooking, and being with family.
Awards/Associations
- American Academy of Pediatrics
- American College of Cardiology
- American Society of Echocardiography
- American Heart Association
- Heart Rhythm outstanding publication award for young electrophysiologists in the area of clinical research, 2022
Publications
Samuel S, Friedman RA, Sharma C, Ganigara M, Mitchell E, Schleien C, Blaufox AD. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval. Heart Rhythm. 2020 Jul 1: S1547-5271(20)306329.
Samuel S, Dhanantwari P, Meyer DB. Myocardial ischaemia and valve insufficiency caused by a dysplastic aortic valve cusp: a previously unreported unique morphologic anomaly. Cardiol Young. 2020 Jul;30(7):1046-1049.
Samuel S, Fountain R, Start D, Karpawich PP. A Unique Case of Sudden Cardiac Death in an Infant. Clin Pediatr (Phila). 2019 Feb;58(2):253-256.
Samuel S, Karpawich PP, Scheurer-Monaghan A. A unique case of facial dysmorphism in an infant. NeoReviews. 2018, Feb; 19(2): 127-129.
Samuel S, Brown K, Patel D. Food additives: An overview of health implications, regulation, and control in the United States. International Public Health Journal. 2018, Jan; 10(1): 33-40.
Brown K, Samuel S, Patel D. Pharmacologic management of Attention deficit hyperactivity disorder in children and adolescents: a review for practitioners. Translational Pediatrics. 2018, Jan; 7(1): 36-47.
Bansal N, Samuel S, Zelin K, Karpawich PP. Ten-Year Clinical Experience with the Lumenless, Catheter-Delivered, 4.1-Fr Diameter Pacing Lead in Patients with and without Congenital Heart. Pacing Clin Electrophysiol. 2017 Jan;40(1):17-25.
Karpawich PP, Bansal N, Samuel S, Sanil Y, Zelin K. 16 Years of Cardiac Resynchronization Pacing Among Congenital Heart Disease Patients: Direct Contractility (dP/dt-max) Screening When the Guidelines Do Not Apply. JACC Clin Electrophysiol. 2017 Aug;3(8):830-841.
Samuel S and Karpawich P. Clinical factors predicting therapeutic response to cardiac resynchronization therapy among congenital heart patients: Select abstracts from Cardiology 2017. World Journal of Pediatric and Congenital Heart Surgery. 2017, Feb; 8(2): 250-96.
Samuel S, Nanjappa S, Cooper CD, Greene JN. Human Metapneumovirus as an important respiratory pathogen in immunocompromised patients. Cancer Control, Journal of the Moffitt Cancer center. 2016, Oct; 23(4): 442-45.
Patient Reviews
About Patient Comments
The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.